Detoxified Cholera Toxin as a Vaccine Adjuvant for Oral Vaccines

Abstract

The invention is directed to immunogenic compositions and vaccines, and methods for the manufacture and treatment and prevention of infections and, in particular, the preparation of immunogenic compositions and vaccines administered in conjunction with a detoxified cholera toxin as an adjuvant and a TLR agonist for oral administration, which may be encapsulated.

Dependencies are inferred from the claim text.